skip to Main Content
Newsfeed image, light gray text on dark gray background

Immuno-Oncology Drug, AM0010, Is Effective in Treating Advanced Pancreatic Cancer

The phase 1/1b trial included 47 advanced pancreatic ductal adenocarcinoma (PDAC) patients. Of the total patients, 22 were treated with AM0010 alone, while 21 patients were given AM0010 in combination with FOLFOX chemotherapy. Both forms of treatment were observed to be effective; however, grade 3/4 treatment of daily doses of AM0010 correlated with thrombocytopenia, anemia,…

Back To Top